Lactational evaluation of recombinant bovine somatotropin with corn and barley diets

Forty-eight Holstein cows were randomly assigned to receive diets containing corn or barley as the primary energy concentrate from wk 4 through 44 postpartum. During wk 14, cows from each grain source group were randomly assigned to receive 0 (control), 10.3, 20.6, and 30.9 mg/cow per d of recombinant bST injected wk 15 through 44 postpartum. Grain source exerted no significant effect on production parameters and efficacy of bST, although milk production tended to be higher with corn diets. Milk production (24.2, 29.2, 31.7, and 29.5 kg/d) and 4% FCM (21.9, 26.2, 28.1, and 28.0 kg/d) were higher for cows injected with bST, and DM intakes (20.9, 22.8, 22.0, and 23.3 kg/d) increased slightly. Percentages of milk fat (3.47, 3.28, 3.39, and 3.52) and protein (3.48, 3.44, 3.44, and 3.38) varied. Lactose, SCC, and body weights were similar for bST and dietary treatments. Diet or bST had no detectable affect on health or reproduction. Injection of bST wk 15 through 44 increased milk production 21 to 31% relative to control animals. Limiting bST use to the latter two-thirds of lactation resulted in an 8 to 17% increase in total yield with only a 0 to 5% increase in lactational DM intake.     

Lactation response of dairy cows receiving bovine somatotropin and fed rations varying in crude protein and undegradable intake protein

Our experiment evaluated lactation and metabolic responses of Holstein cows injected with somidobove (recombinant bST) and fed one of four isocaloric rations containing either 14 (low) or 17% (high) CP and undegradable intake protein of 33 (low) or 40% (high) of CP. Multiparous cows (n = 37) in early lactation, averaging 37 kg/d of milk, received somidobove (640 mg per injection) at 28-d intervals for 112 d and one of four protein rations: low-low, low-high, high-low, and high-high. Nine other multiparous controls were fed low-low ration with no somidobove. On the low-low ration, somidobove significantly increased milk yield by 2.3 kg/d, but not 3.5% FCM (1.7 kg/d), intakes of DM or CP, or milk composition. Milk and 3.5% FCM increased by 1.7 and 2.1 kg/d in cows fed high undegradable intake protein but there was no effect on milk composition, BW, or DM intake. Ration CP had no effect on production variables in cows receiving somidobove. Serum urea was higher in cows fed high CP rations; undegradable intake protein was without effect. Plasma leucine was higher in cows fed high undegradable intake protein. Administration of somidobove to cows fed low-low rations reduced plasma methionine, serum albumin, hemoglobin, and albumin:globulin ratio. Milk production of high producing dairy cows receiving somidobove may be limited by the amount of protein available at the small intestine.     

Evaluation of sometribove in a prolonged-release system in lactating dairy cows--production responses

Primiparous (n = 105) and multiparous (n = 136) Holstein cows were used to evaluate efficacy of sometribove (n-methionyl bovine somatotropin, bST) in a dose titration study. Cows were fed TMR for ad libitum intake, were milked twice daily, and were allocated randomly within parity (1 vs. 2+) to treatments of 0, 250, 500, or 750 mg bST/14 d in a prolonged-release formulation. Subcutaneous injections commenced 60 +/- 3 d postpartum and continued throughout lactation. During a standardized treatment period of 252 d, treatment with increasing dosages of bST increased 3.5% FCM yield in a dose-dependent manner for both primiparous (2.5 kg/d, 10.2%; 3.5 kg/d, 14.3%; and 5.9 kg/d, 24.1%) and multiparous cows (3.1 kg/d, 12.1%; 3.9 kg/d, 15.2%; and 6.8 kg/d, 26.5%). Milk content of fat, protein, lactose, ash, Ca and P, and SCC were not affected by treatment. Over the 252-d treatment period, voluntary intake of energy was increased in bST-treated cows such that BW gain, body condition score, and net energy balance did not differ among treatment groups. Productive efficiency (milk per unit NEL intake corrected for BW change) over the treatment period was significantly increased in a dose-dependent manner for multiparous cows (4.1, 6.8, and 11.0%). Results demonstrated that bST administered in a prolonged-release formulation was efficacious in enhancing milk production and feed efficiency.     

Somatotropin treatment for a second consecutive lactation

Twenty-five Holstein cows were used to examine effects of recombinant bST administration for a second successive lactation on milk yield and composition, BW change, body condition, and health. Treatments were 0 (physiological saline), 10.3, 20.6, and 33 mg bST/d (8, 8, 7, and 3 cows per treatment, respectively). Saline and bST were given daily as subcutaneous injections beginning 4 to 5 wk postpartum and continuing for 38 wk. Somatotropin increased 3.5% FCM yield linearly from 8 to 36% over controls (control FCM was 30.1 kg/d). Milk composition was not affected by bST except that milk from cows given the 10.3-mg dosage had slightly higher Ca and P contents than did milk from cows receiving 0 or 20.6 mg. Cows receiving bST were 9 to 30% more efficient than controls in converting feed to milk. Body weight gain was unaffected by treatment. Average condition score was unchanged for control cows during the first 84 d following initiation of treatment, but declined in cows given bST. Thereafter, condition score increased in a similar manner for all groups. No treatment-related patterns were found in incidence of mastitis, feet and leg problems, ketosis, or milk fever. Blood hormone, chemistry, and hematology revealed no effects of bST treatment other than to raise plasma bST concentrations. Under conditions of this experiment, use of bST during a second consecutive lactation did not change the normal physiology or productive capacity of lactating cows.     

Low doses of bovine somatotropin during the transition period and early lactation improves milk yield, efficiency of production, and other physiological responses of Holstein cows

The objectives of this experiment were to determine whether low doses of bovine somatotropin (bST) during the transition period and early lactation period improved dry matter intake (DMI), body weight (BW), or body condition score (BCS); provoked positive changes in concentrations of somatotropin, insulin, insulin-like growth factor-I (IGF-I), glucose, nonesterified fatty acids, and Ca; or improved milk yield (MY) response without obvious adverse effects on health status. Eighty-four multiparous Holstein cows completed treatments arranged in a 2 x 3 x 2 factorial design that included prepartum and postpartum bST, dry period (30 d dry, 30 d dry + estradiol cypionate, and 60 d dry), and prepartum anionic or cationic diets. Biweekly injections of bST began at 21 +/- 3 d before expected calving date through 42 +/- 2 d postpartum (control = 0 vs. bST = 10.2 mg of bST/d; POSILAC). At 56 +/- 2 d in milk, all cows were injected with a full dose of bST (500 mg of bST/14 d; POSILAC). During the prepartum period and during the first 28 d postpartum, no differences in mean BW, BCS, or DMI were detected between the bST treatment group and the control group. During the first 10 wk of lactation, cows in the bST treatment group had greater mean MY and 3.5% fat-corrected milk yield and lower SCC than did cows in the control group. When cows received a full dose of bST, an increase in milk production through wk 21 was maintained better by cows in the bST group. Mean concentrations of somatotropin, IGF-I, and insulin differed during the overall prepartum period (d -21 to -1). During the postpartum period (d 1 to 28), cows in the bST group had greater mean concentrations of somatotropin and IGF-I in plasma. Concentrations of Ca around calving did not differ because of bST treatment. Results suggest that changes in concentrations of blood measures provoked by injections of bST during the transition period and early lactation period resulted in improved metabolic status and production of the cows without apparent positive or negative effects on calving or health.     

Lactational response of Jersey cows to bovine somatotropin administered daily or in a sustained-release formulation.

Twenty-four Jersey cows were administered either 0 or 15.5 mg of bST/d or 310 mg of bST/14 d to determine the effect on milk yield, milk composition, feed intake, and body weight. Administration of bST was from wk 14 through 42 postpartum. Cows were housed in a tie-stall barn and fed for ad libitum intake a TMR adjusted to one of two energy protein densities according to milk yield. Milk yield of cows administered bST daily or by sustained-released vehicle increased 27.6 and 24.7%, respectively, over that of control cows; FCM increased by 30.3 and 26.7%. Percentages of fat and protein in milk were unaffected by bST treatment. Dry matter intake of cows administered bST was greater than that of control cows, whether expressed as kilograms per day or as a percentage of body weight. Apparent efficiency of yield increased in cows administered bST. No significant change in body weight occurred; however, cows administered bST had lower body condition scores at 42 wk postpartum. This trial demonstrated comparable effects of bST on lactational performance when administered daily or in a 14-d sustained-release vehicle.     

Response to recombinant bovine somatotropin in dairy cows with different genetic merit for milk production

Thirty-nine multiparous cows obtained from two genetic lines were utilized to determine the effect of genetic merit on lactation response to long-term administration of recombinant bST. Cow index ranged from -70 to 456 (mean = 183) and -494 to -88 (mean = -288) kg milk for high and low genetic groups, respectively. Cows were blocked by calving date and randomly assigned to treatment within genetic group. Treatments were 0, 10.3, 20.6, and 30.9 mg somatotropin injected daily from wk 14 through 44 postpartum. Cows were fed one of two total mixed rations. Diet 1 (NE1 = 1.65 Mcal/kg, CP = 18%, and ADF = 22%) was fed from start of lactation to at least 4 wk after initiation of treatment. Cows were switched to diet 2 (NE1 = 1.56 Mcal/kg, CP = 16%, and ADF = 27%) when milk output fell below 25 kg/d. Forty-four week lactation yields were 9800 and 9447 kg milk; 364 and 354 kg fat; and 322 and 309 kg protein for high and low genetic groups, respectively. Milk, milk fat, or protein yield due to somatotropin did not differ between genetic groups. Increasing dosage of bST increased milk, 4% FCM, fat, and protein yields in a linear fashion. Percentages of fat and protein of milk were similar for all treatment groups. Body weight changes were not significantly different among treatments, but condition score changes decreased linearly with increasing dose of bST. Long-term treatment with recombinant bST had no apparent effect on incidence of health problems or reproduction.     

Overall efficacy of chronically administered recombinant bovine somatotropin to lactating dairy cows

Recombinant bST at daily dosages of 0, 10.3, 20.6, and 41.2 mg/d were injected for 266 d into 8, 10, 9, and 9 Holstein cows, respectively. Treatment effects of recombinant bST were assessed for milk production traits, BW, blood components, and health and reproductive variables. Data reported compare controls to all bST-treated cows. There was an average increase of 18% in 3.5% FCM for bST versus control cows. This increase resulted in enhanced feed efficiency for bST cows, as their DM intakes were not elevated above those of the control cows. Recovery of BW was similar between control and bST groups. Milk composition was unaffected except for a slight decrease in protein percentage during the first 9 wk of treatment, and an elevated SCC between wk 19 and 28. Blood parameters were not different between control and bST cows, except for hematocrit, which decreased with bST treatment. The only health and reproductive parameters affected by bST were mastitis and days open, which were increased in the highest dosage groups.     

Influence of bovine somatotropin and nutrition on production and composition of milk from dairy cows.

Forty-eight multiparous Holstein cows were used in an experiment with a 2 x 2 factorial arrangement of treatments to study interactions of bST and nutrient density during wk 5 through 20 postpartum. Main effects were bST (0 or 10.3 mg/d) and diet (control or high protein and energy). The control diet was formulated to contain 16.3% CP and 1.65 Mcal of NEL/kg of DM; the high protein and energy diet was formulated to contain 18% CP and 1.74 Mcal of NEL/kg of DM with additional energy as fat from extruded soybeans and calcium salts of fatty acids. Diet ratios were 50:25:25 for concentrate:alfalfa hay:corn silage (DM basis). Bovine somatotropin increased milk production (40.9 vs. 37.9 kg/d) and production of 4% FCM (35.7 vs. 32.3 kg/d). The high protein and energy diet increased milk production (40.3 vs. 38.5 kg/d); 4% FCM production was higher for high protein and energy plus bST (36.0 kg) than without bST (33.6 kg). Percentage of milk fat was not affected by treatment. Percentage of milk protein was reduced with the high protein and energy diet, presumably because of the added fat, but this reduction was less with high protein and energy plus bST. Dry matter intake was not significantly elevated by bST (23.1 vs. 22.8 kg/d) but was lower for high protein and energy (22.0 vs. 23.8 kg/d). Increased dietary protein and energy with bST augmented the total milk production response.     

Effects of long daily photoperiod and bovine somatotropin (Trobest) on milk yield in cows.

Bovine somatotropin (bST) and exposure to long daily photoperiod increase milk yield of dairy cattle. We tested the hypothesis that long daily photoperiod and bST treatment would increase milk yield in an additive manner in lactating cows. At winter solstice, 40 lactating cows were started on a 140-d experiment; cows were greater than 70 d in milk (DIM) and were balanced for uniformity of DIM and milk yield within parity. Cows were randomly assigned to one of four treatments (10/treatment): 1) natural photoperiod, 2) natural photoperiod + bST (14 mg/d Trobest i.m.), 3) long daily photoperiod (18 h of light and 6 h of darkness/d), or 4) long daily photoperiod + bST. Long daily photoperiod increased fat-corrected milk (FCM) yield 1.9 kg/d versus natural photoperiod. Treatment with bST increased FCM 5.7 kg/d versus natural photoperiod, and long daily photoperiod + bST increased FCM 5.8 kg/d versus long daily photoperiod. Long daily photoperiod + bST was additive, increasing FCM 7.7 kg/d versus natural photoperiod. Serum somatotropin increased with bST, but not photoperiod, and bST increased serum insulin-like growth factor-I. Long daily photoperiod tended to increase prolactin; bST had no effect. Long daily photoperiod + bST increased dry matter intake (DMI) relative to natural photoperiod and natural photoperiod + bST; long daily photoperiod increased DMI relative to natural photoperiod + bST. Photoperiod had no effect on net energy balance; however, bST decreased net energy balance. Generally, body weight and milk composition did not differ among treatments. In conclusion, combination of bST with long-daily photoperiod tended to amplify the increases in milk yield observed with either treatment individually.     

Responses of Holstein cows to a low dose of somatotropin (bST) prepartum and postpartum

Objectives were to evaluate the effects of a low dose of bovine somatotropin (bST) injected prepartum and postpartum on body condition score (BCS), body weight (BW), and milk yield (MY) in cows as well as somatotropin insulin, insulin-like growth factor-I (IGF-I), glucose, and nonesterified fatty acids (NEFA) in plasma. Holstein cows nearing second or later parities were assigned randomly to control (CON = 98) or bST-treated (TRT = 95) groups. Biweekly injections of bST began 21 +/- 3 d before expected calving and continued through 42 d postpartum (CON vs. TRT; 0 vs. 10.2 mg of bST/ d). From 42 to 100 d postpartum, no cows received bST. During yr 1, somatotropin, IGF-I, insulin, NEFA, and glucose were measured in plasma samples from 82 cows. During yr 2, effects of bST on BCS and BW of 111 cows were evaluated, but no blood samples were collected. Milk yields through 100 d of all 193 cows were analyzed. Prepartum treatment with bST resulted in greater prepartum plasma concentrations of somatotropin, insulin, and numerically greater NEFA but did not affect glucose or IGF-I. Postpartum bST increased mean plasma concentrations of somatotropin and NEFA, but not INS, IGF-I, or glucose. Mean BCS of cows did not differ prepartum, around parturition, or postpartum. Although mean BW did not differ prepartum or around calving, cows receiving bST maintained greater BW postpartum. Cows receiving bST tended to have higher MY (6.6%) in the first 60 d of lactation, but differences did not persist through 100 d, including approximately 40 d when no cows received bST. Number of cows that were culled due to health (CON = 3 vs. TRT = 2) or died (CON = 3 vs. TRT = 1) were not affected by treatment. Low doses of bST in the transition period resulted in higher postpartum BW, quicker recovery of body condition during lactation, and significantly more milk during treatment.     

Effect of prepartum dietary energy on condition score, postpartum energy, nitrogen partitions, and lactation production responses

Objectives were to examine the effects of feeding to alter body condition at calving on subsequent full lactation production performance and feed intake, on BW and periparturient blood traits, and on complete energy and N balances and ration digestibility during wk 6, 10, and 14 postpartum. Thirty pluriparous Holstein cows were assigned randomly to two energy intakes from wk 33 of previous lactation through the dry period to create either normal (7.2) or thin (5.8) mean body condition scores at calving (9 = fat, 1 = thin). The thin group was fed 0 kg hominy feed daily; the normal group was fed 2.7 kg daily to supplement forage DM available ad libitum during this period. When compared with the normal group, cows in the thin condition group exhibited less negative body fat balance (-206 vs. -507 g/d); similar milk yield, DM intake, N partitions, and nutrient digestibilities; and lower fat test (3.2 vs. 4.1%) during the balance measurements. Whole blood and serum traits were within normal physiological ranges. Full lactation measurements were similar between treatments except that milk fat percentage was lower and DM intake (as percentage of BW), was higher in the thin condition group. Although mean BW at calving was more (651 vs. 599 kg) for normal condition cows, condition scores and BW were not significantly different at 14 wk postpartum; BW curves indicated similar rates of recovery of weight thereafter. Cows considered underconditioned at parturition mobilized less body fat after calving, resulting in reduced milk fat concentration without significant effects on milk yield, protein, SNF, DM intake, or nutrient utilization.     

Milk production and feed intake of Holstein cows given short (30-d) or normal (60-d) dry periods

Eighty-four Holstein cows were utilized to evaluate effects of dry period (60 d vs. 30 d), with or without estradiol cypionate (ECP) injections to accelerate mammary involution, on prepartum and postpartum dry matter intake (DMI), body weight (BW), body condition score (BCS), and subsequent milk yield (MY). Treatments were arranged in a 3 x 2 x 2 factorial design that included dry period (30 d dry, 30 d dry + ECP, and 60 d dry), prepartum and postpartum bovine somatotropin (bST; 10.2 mg/d), and prepartum anionic or cationic diets. To accelerate mammary involution, ECP (15 mg) was injected intramuscularly at dry-off. No interaction of bST or prepartum diet with dry period length was detected on BW, BCS, or MY. No significant effects of dry period length on prepartum DMI, BW, or BCS were detected. Cows with shorter dry periods maintained postpartum BCS better and tended to have greater DMI immediately postpartum. Mean daily yields of milk for dry period groups did not differ during overall lactation period (1 to 21 wk). Injection of ECP at the onset of the 30-d dry period did not affect MY. No significant differences due to dry period length were detected for milk, 3.5% FCM, or SCM yields during first 10 wk of lactation. Data indicated that a short dry period protocol can be used as a management tool with no loss in the subsequent milk production of dairy cows.     

Effects of sucrose supplementation on dry matter intake,milk yield,and blood metabolites of periparturient Holstein dairy cows

Thirty-four multiparous Holstein dairy cows (780 +/- 17.2 kg body weight; 3.4 +/- 0.08 body condition score) were used in a completely randomized design to evaluate the effects of fermentable carbohydrate source on dry matter (DM) intake, milk production, and blood metabolites of transition cows. Treatments were initiated 30 d before expected calving date. After calving, all cows went onto a similar lactating cow diet. Dry matter intake was measured daily, and milk production and composition were measured weekly for 56 d after calving The control diet consisted of 11.5% ground corn, whereas the treatment diet consisted of sucrose replacing 2.7% of ground corn on a DM basis. Prepartum plasma glucose concentrations were higher (66.3 vs. 69.3 +/- 1.13 mg/dl) for cows fed the diet containing sucrose. Glucose concentrations were not different postpartum. Prepartum and postpartum nonesterified fatty acids, blood urea N, and insulin did not differ between treatments. Substitution of sucrose as a readily available carbohydrate source for ground corn did not affect prepartum or postpartum DM intake. Milk yield, 3.5% fat-corrected milk yield, and milk components did not differ between treatments. Results from this research demonstrated that partially replacing ground corn with sucrose did not enhance prepartum or postpartum intake or performance.     

Milk yields and hormone concentrations of Holstein cows in response to sometribove (somatotropin) treatment during the dry period.

Holstein cows (n = 135) under commercial management were used to determine whether sometribove (recombinant methionyl bST, 25 mg/d) administered during the dry period affected milk yield during the ensuing lactation. Cows scheduled to begin lactations (greater than or equal to 2) during January to March were assigned randomly to treatments of sodium bicarbonate excipient (n = 67) or bST (25 mg/d, n = 68). Subcutaneous injections were given for 14 d, corresponding to d -21 to -7 relative to expected calving date. Days dry prior to first injection (64.0, 60.2) and number of injections received (13.9, 13.8) were similar for control and treatment groups, but days from last injection to calving (8.8, 7.1) differed. No differences in incidence of dystocia or udder edema were detected. Previous lactation yields were 8251 and 7952 kg, and yields for lactations following treatment were 8328 and 7852 kg, based on complete lactation data. Mean test date 3.5% FCM yields for control and treated groups during experimental lactation differed before (30.3 vs. 28.1 kg) but not after (29.5 vs. 28.4 kg) covariance adjustment for previous total lactation milk yield. Test of heterogeneity of regression provided no evidence that respective curves for FCM yield during lactation were not parallel or of different magnitude. Elevation of serum bST during 2 wk of the dry period resulted in no apparent increase in extent of mammogenesis or lactogenesis that was translated into an increase in milk yield.     

Effects of induced parturition and estradiol on feed intake, liver triglyceride concentration, and plasma metabolites of transition dairy cows.

The effect of induced parturition and estradiol on feed intake, liver triglyceride, plasma metabolites, and milk yield was evaluated in fifty-six Holstein cows and heifers. Cows were assigned to treatments on d 260 of gestation and were on trial until d 10 postpartum for measurement of dry matter intake (DMI), plasma metabolites, and liver triglyceride and until d 31 postpartum to measure milk yield. Fourteen animals per group (9 cows and 5 heifers) received either a placebo, 1 mg of fenprostalene, 50 mg of estradiol-17 beta benzoate, or both on d 276 of gestation. Cows that received fenprostalene consumed more dry matter (DM) for the last 8 d prepartum than did cows that did not receive fenprostalene (9.6 kg/d vs. 8.5 kg/d, respectively) but consumed less DM for the first 10 d postpartum (10.9 kg/d vs. 13.1 kg/d, respectively). Cows injected with estradiol-17 beta benzoate tended to consume less DM postpartum than did cows not injected with estradiol-17 beta benzoate (11.3 kg/d vs. 12.7 kg/d, respectively). There was no effect of treatment on milk yield; however, a fenprostalene by day interaction resulted from lower milk yield on d 3, 4, 5, 7, and 10 relative to calving in cows that received fenprostalene. Administration of fenprostalene resulted in a delay in the peak plasma nonesterified fatty acid (NEFA) concentration until 2 d after calving. Plasma glucose concentrations were greatest 1 d prior to calving for cows that received fenprostalene, whereas plasma glucose concentrations peaked on the day of calving for cows that did not receive fenprostalene. Liver triglyceride increased over time; however, there was no effect of treatment on liver triglyceride. Calving induction improved DMI for the last 8 d prepartum, but a concomitant decrease in liver triglyceride after calving did not result. Estradiol-17 beta benzoate had no effect on plasma metabolites or liver triglyceride, indicating that the physiological rise in estradiol prior to calving does not have a primary role in lipolysis or hepatic fatty acid metabolism in the dairy cow.     

Production response of multiparous Holstein cows treated with bovine somatotropin and fed diets enriched with n-3 or n-6 fatty acids

Multiparous cows (n = 59) were blocked by expected calving date and previous milk yield and assigned randomly to treatments to determine the effects of bovine somatotropin (bST; Posilac, Monsanto Animal Agricultural Group, St. Louis, MO) and source of dietary fat on production responses. Diets were provided from calving and included whole, high-oil sunflower seeds [SS; 10% of dietary dry matter (DM); n-6:n-3 ratio of 4.6] as a source of linoleic acid (18:2) or a mixture of Alifet-High Energy and Alifet-Repro (AF; Alifet USA, Cincinnati, OH; 3.5 and 1.5% of dietary DM, respectively; n-6/n-3 ratio of 2.6) as a source of protected n-3 fatty acids. Diets contained 181 versus 188 g of crude protein and 183 versus 186 g of acid detergent fiber/kg of DM and 1.54 versus 1.66 Mcal of net energy for lactation at the actual DM intake for SS versus AF, respectively. Cows received 0 or 500 mg of bST every 10 d from 12 to 70 d in milk (DIM) and at 14-d intervals through 280 DIM. The 2 × 2 factorial combination of diet (SS or AF) with or without bST administration resulted in treatments designated as SSY, SSN, AFY, and AFN, respectively. Data were analyzed as repeated measures using mixed model procedures to determine the effects of diet, bST, and their interactions. Yield of 3.5% fat-corrected milk was not altered by diet, but was increased by 4.0 ± 1.9 kg/d from 12 to 70 DIM and by 5.1 ± 1.2 kg/d from 12 to 280 DIM by bST. Treatment did not affect DM intake or energy balance (EB) nadir. There was an interaction of bST and diet on EB because AF decreased the impact of bST on overall EB and allowed AFY cows to reach a positive EB earlier than SSY cows. Gross feed efficiency adjusted for body weight change was greater for bST-treated cows (1.03 vs. 1.15 ± 0.03 kg of fat-corrected milk/Mcal of net energy for lactation). Circulating insulin-like growth factor-I concentrations were increased by bST (85 vs. 125 ± 8 ng/mL). Body weight, body condition score, and backfat thickness were reduced by bST, but differences between treated and nontreated cows did not differ by 280 DIM. Results indicate cows responded to bST administration in early lactation, but the magnitude of the response was greater after 70 DIM. Source of dietary fat had a minimal effect on most production measurements, but relative to SS, AF decreased the impact of bST on overall EB. Results support the premise that bST administration prolongs the delay in postpartum tissue replenishment.     

Effect of prepartum dry matter intake on liver triglyceride concentration and early lactation.

Depression in feed intake during the final week before calving was hypothesized to be a major factor in the etiology of fatty liver development near parturition. Eleven cows were allowed to eat for ad libitum intake prior to calving (control), and 11 cows were maintained at the same level of DMI recorded during d 21 to 17 prior to calving by force feeding the feed refusals via rumen cannulas. Feed intake by control cows decreased 28% during the final 17 d prior to calving. Lipid triglyceride increased 227 and 75% for control and force-fed cows between d 17 prior to parturition and d 1 following calving. Dry matter intake prior to calving was correlated negatively with liver triglyceride immediately after calving (r = -.80). Plasma glucose concentrations for control and force-fed cows were 63 and 76 mg/dl 2 d prior to calving and also were related closely to liver triglyceride immediately after calving (r = -.50). By d 28 after calving, there were no differences in liver triglyceride between treatments. Cows that were force-fed prior to calving tended to yield milk with greater fat percentage (4.22 vs. 3.88%) and to yield more 3.5% FCM (46.1 vs. 41.7 kg/d) during the first 28 d postpartum.     

Effects of pre- and postpartum dietary starch content on productivity,plasma energy metabolites,and serum inflammation indicators of dairy cows

The objective of this study was to evaluate the effects of the starch content of pre- and postpartum diets on productivity, plasma energy metabolites, and serum markers of inflammation of dairy cows during the calving transition period. Eighty-eight primiparous and multiparous cows were randomly assigned to pre- and postpartum dietary treatments balanced for parity and pretrial body condition score at d 28 ± 3 before expected calving date. Cows were fed either a control [Control; 14.0% starch, dry matter (DM) basis] or high-starch (High; 26.1% starch, DM basis) prepartum diet commencing 28 ± 3 d before expected calving date. Following calving, cows were fed either a high-fiber (HF; 33.8% neutral detergent fiber, 25.1% starch, DM basis) or high-starch (HS; 27.2% neutral detergent fiber, 32.8% starch, DM basis) postpartum diet for the first 20 ± 2 d following calving. Cows fed the High prepartum diet had greater DM intake (12.4 vs. 10.2 kg/d), plasma concentrations of insulin (1.72 vs. 14.2 ng/mL), glucose (68.1 vs. 65.0 mg/dL), and glucagon-like peptide-2 (0.41 vs. 0.32 ng/mL) before parturition, but increased plasma free fatty acid concentration (452 vs. 363 µEq/L) and milk fat yield (1.64 vs. 1.48 kg/d) after parturition. Cows fed the HS postpartum diet had lower plasma free fatty acid (372 vs. 442 µEq/L) and serum haptoglobin (0.46 vs. 0.70 mg/mL) concentrations over a 3-wk period after calving. In addition, there was a tendency for interaction between prepartum and postpartum diets for milk yield, where feeding the HS postpartum diet increased milk yield compared with the HF diet for cows fed the Control prepartum diet (40.8 vs. 37.9 kg/d) but not for cows fed the High prepartum diet. These results suggest that management efforts to minimize the change in diet fermentability during the calving transition by feeding the High prepartum diet, the HF postpartum diet, or both did not increase productivity of dairy cows but increased fat mobilization after calving. Our findings also suggest that feeding high-starch postpartum diets can decrease fat mobilization and serum indicators of systemic inflammation and increase milk production even with the transition from a low-starch prepartum diet.     

Comparison of somatotropin and growth hormone-releasing factor on milk yield, serum hormones, and energy status.

Holstein cows received 12 mg/d of growth hormone-releasing factor (continuous i.v. infusion, n = 5), 14 mg/d of bST (single daily i.m. injection, n = 8), or no treatment (controls, n = 8) for 60 d. Compared with controls (31.6 kg/d), bST and growth hormone-releasing factor increased milk yield to 34.2 and 37.0 kg/d, respectively. The increase in milk yield induced by the growth hormone-releasing factor was greater than that for bST. Milk yield was not different among groups following cessation of treatment. Milk energy output was 24.2 Mcal/d in controls, and growth hormone-releasing factor increased milk energy output to 28.5 Mcal/d. Milk energy output of cows receiving bST was 26.1 Mcal/d. Growth hormone-releasing factor increased DMI (23.2 kg/d) over that of controls (21.1 kg/d), whereas bST (21.5 kg/d) did not. Relative to controls, bST increased averaged daily serum somatotropin from 1.3 to 7.6 ng/ml and insulin-like growth factor-I from 67.5 to 116.0 ng/ml. Relative to bST, growth hormone-releasing factor increased serum somatotropin to 16.3 ng/ml and insulin-like growth factor-I to 202.6 ng/ml. Relative to control (115.8 meq/dl) and bST (158.1 meq/dl), growth hormone-releasing factor increased plasma NEFA (230.3 meq/dl). During treatment, calculated energy balance was negative for cows receiving growth hormone-releasing factor but positive for bST and control cows. Milk composition, body condition score, BW, and apparent digestibility of DM were not different among treatments. We conclude that i.v. infusion of 12 mg/d mg of growth hormone-releasing factor has greater galactopoietic activity than i.m. injections of 14 mg/d of bST.(ABSTRACT TRUNCATED AT 250 WORDS)